Who owns Tvardi Therapeutics, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of TVRD from SEC Form 13F filings across 57 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 57 institutions disclosed 2.2M shares of Tvardi Therapeutics, Inc. worth $4.2M — about 23.7% of shares outstanding; the largest disclosed holder is Slate Path Capital LP. Source: SEC Form 13F filings, parsed by EvidInvest.
57
13F holders
$4.2M
value, 2026 filers
23.7%
of shares outstanding (2.2M sh)
12
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of TVRD's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Slate Path Capital LP | 704,118 | $1.3M | 0.0% | 7.5% | 0.0% |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 344,382 | $654,326 | 0.0% | 3.7% | -0.1% |
| 3 | AMERICAN FINANCIAL GROUP INC | 223,659 | $424,952 | 0.1% | 2.4% | 0.0% |
| 4 | UBS Group AG | 111,133 | $211,153 | 0.0% | 1.2% | +120.3% |
| 5 | SILVERCREST ASSET MANAGEMENT GROUP LLC | 101,034 | $191,965 | 0.0% | 1.1% | 0.0% |
| 6 | BlackRock, Inc. | 95,478 | $181,408 | 0.0% | 1% | -75.4% |
| 7 | RENAISSANCE TECHNOLOGIES LLC | 91,409 | $173,677 | 0.0% | 1% | -0.8% |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 90,350 | $171,741 | 0.0% | 1% | -50.4% |
| 9 | MORGAN STANLEY | 77,845 | $147,905 | 0.0% | 0.8% | +6.8% |
| 10 | Duncan Williams Asset Management, LLC | 63,241 | $120,158 | 0.0% | 0.7% | 0.0% |
| 11 | VANGUARD FIDUCIARY TRUST CO | 44,710 | $84,949 | 0.0% | 0.5% | -4.6% |
| 12 | Russell Investments Group, Ltd. | 43,228 | $82,133 | 0.0% | 0.5% | +85.5% |
| 13 | STATE STREET CORP | 33,900 | $64,410 | 0.0% | 0.4% | -65.1% |
| 14 | SUSQUEHANNA INTERNATIONAL GROUP, LLPNEW | 33,165 | $63,014 | 0.0% | 0.4% | new |
| 15 | AQR CAPITAL MANAGEMENT LLC | 27,096 | $51,483 | 0.0% | 0.3% | -35.8% |
| 16 | NORTHERN TRUST CORP | 21,836 | $41,489 | 0.0% | 0.2% | -55.5% |
| 17 | Savant Capital, LLCNEW | 19,462 | $49,434 | 0.0% | 0.2% | new |
| 18 | GSA CAPITAL PARTNERS LLPNEW | 17,885 | $34,000 | 0.0% | 0.2% | new |
| 19 | DIADEMA PARTNERS LPNEW | 16,607 | $31,553 | 0.0% | 0.2% | new |
| 20 | XTX Topco LtdNEW | 14,868 | $28,249 | 0.0% | 0.2% | new |
| 21 | BROWN ADVISORY INCNEW | 11,200 | $21,280 | 0.0% | 0.1% | new |
| 22 | Arax Advisory Partners | 11,003 | $20,906 | 0.0% | 0.1% | +32.0% |
| 23 | Qube Research & Technologies LtdNEW | 10,210 | $19,399 | 0.0% | 0.1% | new |
| 24 | Persistent Asset Partners LtdNEW | 4,253 | $8,081 | 0.0% | 0% | new |
| 25 | PNC Financial Services Group, Inc. | 3,518 | $6,685 | 0.0% | 0% | +577.8% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.